Inbios Reagents 96463
Summary
AI-generated · Mar 13, 2026Awarding a sole-source, firm-fixed-price contract to InBios International, Inc. for the InBios DENV Detect IgM Capture ELISA Kit, the only FDA-approved serology test for dengue diagnosis, to support the Dengue Branch Diagnostic Laboratory’s ongoing dengue surveillance program.
Under FAR 6.103-1 SAP, this is not a competitive procurement, but quotations/responses received within 15 days of the notice will be considered. The government will decide at its discretion whether to pursue competition, and information received will typically be used to determine if a competitive procurement should be conducted. If interested, submit a quotation to the contract specialist by the deadline specified in the notice.
The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to InBios International, Inc. for InBios DENV Detect TM IgM Capture Elisa Kit. The InBios DENV Detect TM IgM Capture Elisa Kit is the only serology test approved by the FDA for dengue diagnosis. This test is performed as part of the ongoing DENV surveillance program at the Dengue Branch Diagnostic Laboratory. This contract action is for supplies for which the Government intends to solicit and negotiate with only one source under the authority of Revolutionary FAR Overhaul 6.103-1 (SAP). This notice of intent is not a request for competitive quotations; however, all quotations/responses received within 15 days of the issuance of this notice shall be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at email qsx8@cdc.gov by March 27, 2026 before 5pm EST.
From Special Notice posted on Mar 12, 2026The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to InBios International, Inc. for InBios DENV Detect TM IgM Capture Elisa Kit. The InBios DENV Detect TM IgM Capture Elisa Kit is the only serology test approved by the FDA for dengue diagnosis. This test is performed as part of the ongoing DENV surveillance program at the Dengue Branch Diagnostic Laboratory. This contract action is for supplies for which the Government intends to solicit and negotiate with only one source under the authority of Revolutionary FAR Overhaul 6.103-1 (SAP). This notice of intent is not a request for competitive quotations; however, all quotations/responses received within 15 days of the issuance of this notice shall be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at email qsx8@cdc.gov by March 27, 2026 before 5pm EST.
From Special Notice posted on Mar 23, 2026Notice history
2-
Special Notice Posted Mar 12, 2026
-
Special Notice LATEST Posted Mar 23, 2026View changes (1)
- Response Deadline: Mar 17, 2026 → Mar 27, 2026
Details
Award Information
Not yet awarded
Contacts
Agency
Place of Performance
USA